CWA Asset Management Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.94M | Buy |
38,429
+8,447
| +28% | +$989K | 0.15% | 145 |
|
|
2026
Q1 | $3.61M | Sell |
29,982
-25,610
| -46% | -$2.96M | 0.12% | 177 |
|
|
2025
Q4 | $5.85M | Buy |
55,592
+25,736
| +86% | +$2.42M | 0.21% | 100 |
|
|
2025
Q3 | $2.51M | Sell |
29,856
-7,182
| -19% | -$592K | 0.09% | 193 |
|
|
2025
Q2 | $2.93M | Sell |
37,038
-2,386
| -6% | -$190K | 0.12% | 160 |
|
|
2025
Q1 | $3.54M | Buy |
39,424
+13,075
| +50% | +$1.22M | 0.17% | 125 |
|
|
2024
Q4 | $2.62M | Sell |
26,349
-11,332
| -30% | -$1.17M | 0.13% | 145 |
|
|
2024
Q3 | $4.28M | Buy |
+37,681
| New | +$4.48M | 0.23% | 93 |
|
|
2024
Q1 | $2.17M | Buy |
16,439
+1,275
| +8% | +$157K | 0.13% | 141 |
|
|
2023
Q4 | $1.65M | Buy |
15,164
+2,815
| +23% | +$292K | 0.11% | 130 |
|
|
2023
Q3 | $1.27M | Sell |
12,349
-1,077
| -8% | -$116K | 0.09% | 129 |
|
|
2023
Q2 | $1.55M | Buy |
13,426
+684
| +5% | +$77.7K | 0.11% | 117 |
|
|
2023
Q1 | $1.36M | Sell |
12,742
-351
| -3% | -$37.9K | 0.1% | 117 |
|
|
2022
Q4 | $1.45M | Sell |
13,093
-2,702
| -17% | -$276K | 0.12% | 123 |
|
|
2022
Q3 | $1.36M | Buy |
15,795
+1,267
| +9% | +$113K | 0.13% | 103 |
|
|
2022
Q2 | $1.32M | Buy |
14,528
+1,486
| +11% | +$132K | 0.12% | 110 |
|
|
2022
Q1 | $1.07M | Buy |
13,042
+4,111
| +46% | +$324K | 0.08% | 126 |
|
|
2021
Q4 | $684K | Sell |
8,931
-1,284
| -13% | -$102K | 0.05% | 159 |
|
|
2021
Q3 | $767K | Sell |
10,215
-72,940
| -88% | -$5.55M | 0.06% | 146 |
|
|
2021
Q2 | $6.49M | Buy |
83,155
+9,756
| +13% | +$726K | 0.53% | 55 |
|
|
2021
Q1 | $5.4M | Sell |
73,399
-77,827
| -51% | -$5.74M | 0.49% | 62 |
|
|
2020
Q4 | $11.8M | Buy |
151,226
+16,367
| +12% | +$1.25M | 1.24% | 26 |
|
|
2020
Q3 | $10.7M | Buy |
134,859
+25,727
| +24% | +$2.02M | 1.43% | 21 |
|
|
2020
Q2 | $8.05M | Sell |
109,132
-4,520
| -4% | -$340K | 1.41% | 21 |
|
|
2020
Q1 | $8.34M | Buy |
113,652
+10,402
| +10% | +$818K | 1.59% | 22 |
|
|
2019
Q4 | $8.96M | Sell |
103,250
-567
| -0.5% | -$46.6K | 1.44% | 18 |
|
|
2019
Q3 | $8.34M | Buy |
103,817
+9,190
| +10% | +$737K | 1.34% | 21 |
|
|
2019
Q2 | $7.57M | Buy |
94,627
+10,576
| +13% | +$810K | 1.3% | 18 |
|
|
2019
Q1 | $6.67M | Buy |
84,051
+12,581
| +18% | +$941K | 1.29% | 20 |
|
|
2018
Q4 | $5.21M | Buy |
71,470
+7,403
| +12% | +$523K | 1.21% | 20 |
|
|
2018
Q3 | $4.34M | Buy |
64,067
+4,819
| +8% | +$307K | 0.96% | 39 |
|
|
2018
Q2 | $3.43M | Buy |
59,248
+4,120
| +7% | +$232K | 0.8% | 48 |
|
|
2018
Q1 | $2.87M | Buy |
55,128
+7,759
| +16% | +$419K | 0.71% | 54 |
|
|
2017
Q4 | $2.54M | Buy |
47,369
+13,564
| +40% | +$752K | 0.67% | 58 |
|
|
2017
Q3 | $2.06M | Buy |
33,805
+1,900
| +6% | +$115K | 0.6% | 62 |
|
|
2017
Q2 | $1.95M | Buy |
31,905
+4,165
| +15% | +$254K | 0.62% | 65 |
|
|
2017
Q1 | $1.68M | Buy |
27,740
+2,763
| +11% | +$168K | 0.57% | 60 |
|
|
2016
Q4 | $1.4M | Buy |
24,977
+5,551
| +29% | +$325K | 0.6% | 59 |
|
|
2016
Q3 | $1.16M | Buy |
19,426
+2,680
| +16% | +$157K | 0.64% | 52 |
|
|
2016
Q2 | $921K | Buy |
16,746
+3,293
| +24% | +$175K | 0.56% | 57 |
|
|
2016
Q1 | $679K | Buy |
13,453
+1,713
| +15% | +$83.9K | 0.69% | 47 |
|
|
2015
Q4 | $592K | Buy |
+11,740
| New | +$592K | 0.67% | 52 |
|
Other funds holding MRK
LMFP
ATO
QP
CWA Asset Management Group's MRK Position: Q2 2026 in Review
CWA Asset Management Group increased its Merck (MRK) stake by 28% in Q2 2026, buying an estimated $989K and bringing the position to 38,429 shares worth $4.94M. The position accounts for 0.15% of the portfolio, ranked #145.
CWA Asset Management Group first reported a position in MRK in Q4 2015 and has held it in 42 quarters since. The position peaked at $11.8M in Q4 2020. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- CWA Asset Management Group held 38,429 shares of Merck worth $4.94M as of Q2 2026.
- CWA Asset Management Group bought 8,447 Merck shares in Q2 2026, an estimated $989K.
- Merck made up 0.15% of CWA Asset Management Group's portfolio in Q2 2026, its #145 holding.
- CWA Asset Management Group first reported a position in Merck in Q4 2015 and has held it in 42 quarters since.
- CWA Asset Management Group's Merck position peaked at $11.8M in Q4 2020.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.